Ionis Pharmaceuticals, Inc. (IONS) stock analysis
IONS · Ionis Pharmaceuticals, Inc.
Latest recorded price: USD 28.01
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 17.1%, free cash flow margin -33.9%, ROIC -72.2%. The model flags 2 risk signals for this company (1 high severity).
Similar companies in Healthcare
- Iovance Biotherapeutics, Inc. (IOVA)
- Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
- Korsana Biosciences, Inc. (KRSA)
- Krystal Biotech, Inc. - Common Stock (KRYS)
- Kymera Therapeutics, Inc. - Common Stock (KYMR)
- Ligand Pharmaceuticals Incorporated - Common Stock (LGND)
- Madrigal Pharmaceuticals, Inc. - Common Stock (MDGL)
- MeiraGTx Holdings plc (MGTX)